Nitrogen Tridentate Iridium Complex for OLED Rigidity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing tris-bidentate iridium complexes for OLEDs lack sufficient rigidity, stability, and ease of synthesis, limiting their luminous efficiency and practical application.

Innovation Solution

Development of an iridium complex with a nitrogen-containing tridentate ligand that provides strong rigidity, high stability, and ease of synthesis, allowing for modification of valence states and formal charges, enabling its use in OLEDs and potential medical applications.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If existing tris-bidentate iridium complex structures are used, then emission properties are suitable, but rigidity and stability are insufficient

Engineering Contradiction:
Improvecomplex stabilityVSAvoidcomplex structure
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent combines a nitrogen-containing tridentate ligand with a bidentate ligand to form a composite iridium complex structure. The tridentate ligand provides rigidity and stability through its unique nitrogen-containing heterocyclic framework, while the bidentate ligand complements the overall structure. This composite approach resolves the contradiction by achieving enhanced stability without excessive structural complexity.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The complex is divided into distinct functional segments: a nitrogen-containing tridentate ligand segment providing rigidity and stability, and a bidentate ligand segment contributing to emission properties. This segmentation allows each part to optimize its specific function while maintaining overall structural balance.

Inventive Principle:
Principle #1Segmentation

2Productivity

If complex structures are designed to improve rigidity and stability, then luminous efficiency increases, but ease of synthesis decreases

Engineering Contradiction:
Improveluminous efficiencyVSAvoidease of synthesis
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent modifies molecular parameters by introducing specific nitrogen-containing heterocyclic structures with defined electronic and steric properties. These parameter changes enhance rigidity and luminous efficiency while maintaining synthetic accessibility through well-established organic synthesis methods for heterocyclic compounds.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The nitrogen-containing tridentate ligand acts as an intermediary structure that bridges the requirements for high luminous efficiency (rigidity) and ease of synthesis. Its modular design allows it to be synthesized through standard organic chemistry procedures, then coordinated to iridium in a straightforward one-step process.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If the iridium complex structure is modified to change valence state or formal charge, then application versatility increases, but synthesis complexity increases

Engineering Contradiction:
Improveapplication versatilityVSAvoidsynthesis complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The nitrogen-containing tridentate ligand framework is designed with universal characteristics that allow the same core structure to support multiple valence states and formal charges. By simply adjusting the substitution patterns on the heterocyclic rings, the complex can be adapted for different applications (OLEDs, medical imaging) without fundamentally changing the synthesis route.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS10008680B2Iridium complex and nitrogen-containing tridentate ligand
Publication Date: 2018.06.26 NATIONAL TSING HUA UNIVERSITY
  • US10008680B2 patent drawing
  • US10008680B2 patent drawing
  • US10008680B2 patent drawing

AI summary

An iridium complex and a nitrogen-containing tridentate ligand are provided. The iridium complex is represented by below formula:wherein R1 and R1′ are each independently substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C6-C12 aryl, or —CmF2m+1, m is an integer of 0 to 3; R2 and R2′ are each independently hydrogen, substituted or unsubstituted C1-C12 alkyl, or substituted or unsubstituted C6-C12 aryl; p and p′ are each independently 0 or 1; R3, R3′, R4 and R4′ are each independently hydrogen, fluorine, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C1-C6 alkoxyl, or substituted or unsubstituted C6-C12 aryl; q and q′ are each independently an integer of 0 to 3; r and r′ are each independently an integer of 0 to 4; X1 to X7 are each independently carbon or nitrogen; A is —O—, —CH2—, or —CR2—, R is methyl, ethyl, or propyl; and a is 0 or 1.